The deal was a bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.
Sources familiar with the matter told CNBC's David Faber earlier Tuesday that Amgen is prepared to defend the acquisition, with one source adding the company expects to "win big."
Representatives for Amgen and for Horizon Therapeutics did not immediately respond to a request for comment from CNBC.The two drugmakers said in February that the FTC sent themThousand Oaks, California-based Amgen to buy Horizon Therapeutics in early December and said it expected to complete the sale in the first half of this year.for key treatments over the next decade.CNBC Health & Science
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FTC to block Amgen's $27.8 billion deal for Horizon Therapeutics - sourceThe U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc's $27.8 billion deal to buy Horizon Therapeutics PLC , a person familiar with the matter told Reuters.
Consulte Mais informação »
Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen dealThe deal is bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.
Consulte Mais informação »
FTC Poised to Block Amgen’s $27.8 Billion Deal for Horizon TherapeuticsThe Federal Trade Commission is preparing to block Amgen’s $28 billion deal to buy Horizon Therapeutics
Consulte Mais informação »
Horizon shares sink on report that FTC will sue to block takeover by AmgenShares of Horizon Therapeutics Inc. plunged 15% in extended trading Monday after Bloomberg News reported the FTC is expected to file a lawsuit to block Amgen...
Consulte Mais informação »
Ray Therapeutics Tackles a Rare Blinding Disease With $100 Million in FinancingGene therapies may help a wider group of patients with retinitis pigmentosa, a vision disorder that leads to blindness. Ray Therapeutics is looking to treat people who’ve lost their sight, while other startups are aiming at earlier stages.
Consulte Mais informação »
Robocall company behind 'billions' of illegal calls sued by FTCXCast Labs, a company accused of helping make billions of illegal robocalls, was sued on Friday by the U.S. Federal Trade Commission, which asked the court to order the company to stop the practice.
Consulte Mais informação »